Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitro

30 Jun 2017

Abstract excerpt

Influenza A virus is a negative RNA stranded virus of the family Orthomyxoviridae, and represents a major public health threat, compounding existing disease conditions. Influenza A virus replicates rapidly within its host and the segmented nature of its genome facilitates re-assortment, whereby whole genes are exchanged between influenza virus subtypes during replication. Antiviral medications are important...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to interferon and immune responses
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28713784
DOI: 10.3389/fcimb.2017.00304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Novel and Efficacious Chemical Compounds that Disturb Influenza A Virus Entry in vitroPMID 28713784Read ↗

A cell-based screening system for influenza A viral RNA transcription/replication inhibitorsSemantic proximity Read ↗

The emerging influenza virus threat: status and new prospects for its therapy and control.Semantic proximity Read ↗

New treatments for influenzaSemantic proximity Read ↗

Influenza pharmacotherapy: present situation, strategies and hopes.Semantic proximity Read ↗

Broad-Spectrum Antiviral Strategies and Nucleoside AnaloguesSemantic proximity Read ↗

Investigating the Molecular Basis of Antiviral Resistance in the Perspective of Influenza A VirusSemantic proximity Read ↗

Influenza Viruses: Harnessing the Crucial Role of the M2 Ion-Channel and Neuraminidase toward Inhibitor DesignSemantic proximity Read ↗

Insights into RNA-dependent RNA Polymerase Inhibitors as Antiinfluenza Virus AgentsSemantic proximity Read ↗

Influenza neuraminidase: A druggable target for natural productsSemantic proximity Read ↗

<i>Ex Vivo</i> Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A VirusesSemantic proximity Read ↗

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA VirusesSemantic proximity Read ↗

Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.